255 related articles for article (PubMed ID: 29097210)
1. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Chang X; Zhu W; Zhang H; Lian S
Clin Exp Dermatol; 2017 Aug; 42(6):614-621. PubMed ID: 28597996
[TBL] [Abstract][Full Text] [Related]
3. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
Zhang L; Ye L; Xu Z; Jin Y; Song D
Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217.
Luan W; Zhang X; Ruan H; Wang J; Bu X
J Cell Physiol; 2019 Sep; 234(9):16609-16618. PubMed ID: 30779126
[TBL] [Abstract][Full Text] [Related]
5. Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p/GLS axis.
Lu R; Zhang X; Li X; Wan X
Int J Clin Exp Pathol; 2020; 13(7):1791-1801. PubMed ID: 32782707
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
[TBL] [Abstract][Full Text] [Related]
7. The NF-κB member p65 controls glutamine metabolism through miR-23a.
Rathore MG; Saumet A; Rossi JF; de Bettignies C; Tempé D; Lecellier CH; Villalba M
Int J Biochem Cell Biol; 2012 Sep; 44(9):1448-56. PubMed ID: 22634383
[TBL] [Abstract][Full Text] [Related]
8. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
Zhou Q; Zhan H; Lin F; Liu Y; Yang K; Gao Q; Ding M; Liu Y; Huang W; Cai Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902882
[TBL] [Abstract][Full Text] [Related]
9. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
10. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic glutamine metabolism by miR-122.
Sengupta D; Cassel T; Teng KY; Aljuhani M; Chowdhary VK; Hu P; Zhang X; Fan TW; Ghoshal K
Mol Metab; 2020 Apr; 34():174-186. PubMed ID: 32180557
[TBL] [Abstract][Full Text] [Related]
13. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
14. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
Chang X; Zhang H; Lian S; Zhu W
Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism.
Liu F; Li Y; Liu G
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3282-3289. PubMed ID: 28770953
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
17. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.
Tong Y; Guo D; Lin SH; Liang J; Yang D; Ma C; Shao F; Li M; Yu Q; Jiang Y; Li L; Fang J; Yu R; Lu Z
Mol Cell; 2021 Jun; 81(11):2303-2316.e8. PubMed ID: 33991485
[TBL] [Abstract][Full Text] [Related]
18. BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR‑204.
Cai B; Zheng Y; Ma S; Xing Q; Wang X; Yang B; Yin G; Guan F
Int J Oncol; 2017 Dec; 51(6):1941-1951. PubMed ID: 29075789
[TBL] [Abstract][Full Text] [Related]
19. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
20. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]